AstraZeneca reported $10.11B in Operating Expenses for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Abbvie ABBV:US USD 9.62B 590M
Alcon AG ALC:SW USD 2.15B 215M
Amgen AMGN:US USD 4.61B 695M
Artemis Alpha ATS:LN GBP 833K 39K
AstraZeneca AZN:LN USD 10.11B 376M
AstraZeneca AZN:SS USD 10.11B 376M
Astrazeneca AZN:US USD 10.11B 376M
Bayer BAYN:GR EUR 10.57B 486M
Biogen BIIB:US USD 1.84B 650.7M
Bristol Myers Squibb BMY:US USD 9.46B 716M
Eli Lilly And LLY:US USD 5.47B 200.3M
Fresenius FRE:GR EUR 9.96B 384M
Fresenius Medical Care FME:GR EUR 4.65B 20.48M
Genmab GEN:DC DKK 2.56B 406M
Gilead Sciences GILD:US USD 5.12B 917M
GlaxoSmithKline GSK:LN GBP 5.51B 1.13B
Hikma Pharmaceutical HIK:LN USD 1.24B 280M
Merck MRK:GR EUR 4.77B 199M
Merk MRK:US USD 10.32B 624M
Novartis NOVN:VX USD 11.05B 378M
Orion ORNBV:FH EUR 253.8M 7.4M
Pfizer PFE:US USD 19.12B 5.9B
Philips PHIA:NA EUR 5.25B 588M
Recordati REC:IM EUR 362.35M 11.63M
Regeneron Pharmaceuticals REGN:US USD 2.27B 555.1M
Roche Holding ROG:VX 25.06B 4.31B